Expertise in
26
conditions

Pierre Tattevin

CHU Rennes
Rennes, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
26
conditions
CHU Rennes
Rennes, FR 

Overview

Pierre Tattevin practices practicing medicine in Rennes, France.

Mr. Tattevin is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Endocarditis, Infective Endocarditis, Brain Abscess, Pancreaticoduodenectomy, and Vitrectomy.

He is actively involved in clinical research, co-authoring 412 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

CHU Rennes
Rennes, France
Other Locations
Room 3400, Building 30, 1001 Potrero Avenue, San Francisco, CA 94110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Enrollment Status: Recruiting
Publish Date: February 20, 2026
HIV Prevention in France : Dat'AIDS Prevention
HIV Prevention in France : Dat'AIDS Prevention
Enrollment Status: Recruiting
Publish Date: January 15, 2026
Pneumocystis Pneumonia Diagnosis in HIV- Patients: Assessment of the Real Time Polymerase Chain Reaction Quantification on Oropharyngeal Rinse
Pneumocystis Pneumonia Diagnosis in HIV- Patients: Assessment of the Real Time Polymerase Chain Reaction Quantification on Oropharyngeal Rinse
Enrollment Status: Completed
Publish Date: June 15, 2026
Intervention Type: Other
Study Phase: Not Applicable
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Enrollment Status: Completed
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drugs: Levofloxacin, Rifampicin
Study Phase: Phase 3
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Enrollment Status: Completed
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drug: Amoxicillin
Study Phase: Phase 3
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Enrollment Status: Completed
Publish Date: May 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

412 Total Publications

Fosfomycin trometamol prophylaxis for recurrent urinary tract infections in male and female patients with urological comorbidities.
Fosfomycin trometamol prophylaxis for recurrent urinary tract infections in male and female patients with urological comorbidities.
Journal: Infectious diseases (London, England)
Published: May 23, 2026

Frequently Asked Questions about Pierre Tattevin

Is Pierre Tattevin a top-rated expert for Endocarditis?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre Tattevin is classified as an Elite expert for Endocarditis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre Tattevin participate in research or clinical trials?

Yes. Pierre Tattevin has published 412 articles and abstracts on conditions like Endocarditis. You can view a list of Pierre Tattevin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tattevin's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 81 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile